Thus, among ∼20, 000 genes analyzed for expression levels, mRNA levels of ERBB2- and ESR1-related genes emerge as those crucial in mirroring tumor susceptibility to anti-HER2 therapy. The gene discussed is ERBB2; the disease is neoplasm.